Global Targeted Drug Delivery Market Size Report Segmented by Technology (Nanoparticles, Liposomes, ADCs), Route of Administration (Injectable, Oral, Pulmonary, Transdermal, Nasal), Application (Oncology, CVDs, Neurological Disorders), Regional Forecast to 2031

This report by Medi-Tech Insights provides thesize of the global targeted drug delivery market at theregional and country-level from 2024 to 2031. The report further segments the market by technology, route of administration, application, and end user.

• Market Size & Forecast (2024-2031), By Technology, USD Billion
  • Nanoparticles
  • Liposomes
  • Antibody-drug Conjugates (ADCs)
  • Microspheres and Microcapsules
  • Other Technologies

• Market Size & Forecast (2024-2031), By Route of Administration, USD Billion
  • Injectable
  • Oral
  • Pulmonary
  • Transdermal
  • Nasal
  • Other Delivery Routes

• Market Size & Forecast (2024-2031), By Application, USD Billion
  • Oncology
  • Cardiovascular Diseases (CVDs)
  • Neurological Disorders
  • Infectious Diseases
  • Respiratory Diseases
  • Metabolic Disorders
  • Other ns

• Market Size & Forecast (2024-2031), By End User, USD Billion
  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutes
  • Hospitals and Clinics
  • Other End Users

• Market Size & Forecast (2024-2031), By Region, USD Billion
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa